These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Autonomic dysfunction in primary Raynaud's phenomenon. Koszewicz M; Gosk-Bierska I; Bilińska M; Podemski R; Budrewicz S; Adamiec R; Słotwiński K Int Angiol; 2009 Apr; 28(2):127-31. PubMed ID: 19367242 [TBL] [Abstract][Full Text] [Related]
6. [Serial computed thermography for Raynaud's phenomenon of patient with progressive systemic sclerosis (PSS)]. Tomono N; Kuriyama T; Mori M; Takahashi Y; Mitsuda T; Aihara Y; Yokota S Ryumachi; 1996 Jun; 36(3):522-7. PubMed ID: 8779789 [TBL] [Abstract][Full Text] [Related]
7. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM; Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489 [TBL] [Abstract][Full Text] [Related]
8. The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon. Anderson ME; Moore TL; Lunt M; Herrick AL Rheumatology (Oxford); 2007 Mar; 46(3):533-8. PubMed ID: 17018538 [TBL] [Abstract][Full Text] [Related]
9. Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon. Furspan PB; Chatterjee S; Mayes MD; Freedman RR Rheumatology (Oxford); 2005 Apr; 44(4):488-94. PubMed ID: 15695304 [TBL] [Abstract][Full Text] [Related]
10. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476 [TBL] [Abstract][Full Text] [Related]
11. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients. Pistorius MA; Planchon B; de Faucal P Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791 [TBL] [Abstract][Full Text] [Related]
12. Cold stimulus fingertip lacticemy test--an effective method to monitor acute therapeutic intervention on primary Raynaud's phenomenon and systemic sclerosis. Fontenelle SM; Kayser C; Pucinelli ML; Andrade LE Rheumatology (Oxford); 2008 Jan; 47(1):80-3. PubMed ID: 18077495 [TBL] [Abstract][Full Text] [Related]
14. Raynaud's phenomenon and systemic sclerosis. Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438 [TBL] [Abstract][Full Text] [Related]
15. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon. Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193 [TBL] [Abstract][Full Text] [Related]
16. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension. Wigley FM Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460 [TBL] [Abstract][Full Text] [Related]
17. [Status of the mechanisms of autonomic regulation in Raynaud's disease]. Tabeeva GR Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(5):11-3. PubMed ID: 1654687 [TBL] [Abstract][Full Text] [Related]
18. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Pancera P; Sansone S; Presciuttini B; Montagna L; Cerù S; Lunardi C; Lechi A Clin Sci (Lond); 1999 Jan; 96(1):49-57. PubMed ID: 9857106 [TBL] [Abstract][Full Text] [Related]
19. [Raynaud's phenomenon]. Sprynger M Rev Med Liege; 2004 Jun; 59(6):378-84. PubMed ID: 15346976 [TBL] [Abstract][Full Text] [Related]
20. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers. Abou-Raya A; Abou-Raya S; Helmii M J Rheumatol; 2008 Sep; 35(9):1801-8. PubMed ID: 18709692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]